Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
MID1 Gene Opitz G syndrome NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
NOP56 Gene Spinocerebellar ataxia type 36, autosomal dominant NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
NOP56 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genomic UnityⓇ Ataxia Repeat Expansion Analysis (STR analysis of 16 loci) Variantyx, Inc. United States | 15 | 13 |
|
Genomic UnityⓇ Comprehensive Ataxia Analysis (includes STR analysis of 16 loci) Variantyx, Inc. United States | 52 | 53 |
|
Movement diseases (WES based NGS panel of 931 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 10 | 930 |
|
PANEL-3 SCA: SCA10, SCA12, SCA17 & SCA36 Laboratorio de Genetica Clinica SL Spain | 1 | 4 |
|
HEREDITARY ATAXIAS EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 1202 |
|
Codex Genetics Limited Hong Kong | 1 | 490 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
SCA36 (NOP56) Genetic Testing (Repeat expansion) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 1 | 1 |
|
Spinocerebellar ataxia: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 38 | 37 |
|
Spinocerebellar Ataxia Repeat Panel (SCA 8, 10, 12, 17, 36, & DRPLA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 6 | 6 |
|
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 12 | 12 |
|
NOP56 (SCA36) Repeat Expansion Fulgent Genetics United States | 1 | 1 |
|
Ataxia Repeat Expansion Analysis Fulgent Genetics United States | 19 | 15 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 11 | 11 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.